The US Food and Drug Administration (FDA) has approved Neurelis’ diazepam nasal spray, Valtoco, for the short-term treatment ... small-molecule drugs and peptides. The FDA had previously awarded the ...

As for our AM-125 nasal spray, we have partnering discussions ongoing with several parties. The same goes for AM-111, a cell-penetrating peptide for the treatment of acute hearing loss ...

Partnering discussions are also ongoing regarding AM-125, a patented nasal spray for the treatment of ... a cell-penetrating peptide for the treatment of acute hearing loss, which has orphan ...

RNA Delivery In 2024, Altamira made further progress with the development of its peptide based xPhore ... preservative free nasal spray for the treatment of allergic rhinitis, agreed with ...

In 2024, Altamira made further progress with the development of its peptide based xPhore™ nanoparticle platform ... which commercializes Bentrio®, a drug free, preservative free nasal spray for the ...

Nasal spray tech facilitates the delivery of proteins, small-molecule drugs and peptides. Credit: 1777177/Shutterstock. The US Food and Drug Administration (FDA) has approved Neurelis’ diazepam nasal ...

Zavegepant 10 mg nasal spray provided rapid and safe relief from acute migraine attacks but did not exhibit long-term superiority over oral calcitonin gene-related peptide receptor antagonists.

Researchers at Tel Aviv University say they have developed an effective, inexpensive, and simple COVID-19 vaccine that can be stored at room temperature and administered as a nasal spray.

The FDA has expanded the approval of Valtoco (diazepam nasal spray) to include treatment of seizure clusters in patients aged 2 to 5 years.

An antidepressant containing a form of the drug ketamine has been added to the Pharmaceutical Benefits Scheme (PBS), making ...

The FDA has approved Atzumi (dihydroergotamine) nasal powder for the acute treatment of migraine with or without aura in adults.